Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Last Updated: 2026

Siegfried Holding

Rank#3654

Market Cap3.92B

CountrySwitzerland

Summary

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

History

Siegfried Holding AG was founded in 1977 as a small family-owned business in Basel, Switzerland. Since then, it has grown into a leading biopharmaceutical company and is involved in research and development in the fields of oncology and endocrinology. The company is committed to bringing innovative medicines to the market in order to improve patient outcomes.

Mission

Our dream is to enable people to become more irresistibly compelling and seriously relevant!

Vision

Our vision is to be the leader in research, development and delivery of safe, effective and targeted treatments for patients suffering from cancer and endocrine diseases.

References

https://de.wikipedia.org/wiki/Siegfried_Holding

https://www.investing.com/equities/siegfried-holding-ltd

https://finance.yahoo.com/quote/SFZN.SW/profile?p=SFZN.SW

https://www.comparably.com/companies/the-siegfried-group/mission

https://www.crunchbase.com/organization/siegfried-irvine

https://companiesmarketcap.com/

https://www.siegfried.ch

Leadership team

Dr. Wolfgang Wienand Ph.D. (Chief Exec. Officer)

Dr. Jurgen Roos Ph.D. (Chief Scientific Officer)

Dr. Reto Suter Ph.D. (Chief Financial Officer)

Products / Services

Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical

Number of Employees

1,000 - 20,000

Address

Zofingen, Aargau, Switzerland

Established

1873-01-01

Net Income

S_100M_500M

Revenue

$1B+

Traded as

SFZN.SW

Website

https://www.siegfried.ch

Social Media

Last Updated: 2026

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More

Last Updated: 2026

Siegfried Holding

Rank#3654

Market Cap3.92B

CountrySwitzerland

Summary

History

Mission

Our dream is to enable people to become more irresistibly compelling and seriously relevant!

Vision

Our vision is to be the leader in research, development and delivery of safe, effective and targeted treatments for patients suffering from cancer and endocrine diseases.

References

https://de.wikipedia.org/wiki/Siegfried_Holding

https://www.investing.com/equities/siegfried-holding-ltd

https://finance.yahoo.com/quote/SFZN.SW/profile?p=SFZN.SW

https://www.comparably.com/companies/the-siegfried-group/mission

https://www.crunchbase.com/organization/siegfried-irvine

https://companiesmarketcap.com/

https://www.siegfried.ch

Leadership team

Dr. Wolfgang Wienand Ph.D. (Chief Exec. Officer)

Dr. Jurgen Roos Ph.D. (Chief Scientific Officer)

Dr. Reto Suter Ph.D. (Chief Financial Officer)